General Announcement::ASX:TLX; Nasdaq:TLX - IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
16-Apr-2025 04:59:42
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX - IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate
Announcement Reference
SG250416OTHRJBYH
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
16/04/2025 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX - IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate

Attachments

20250416 IPAX-Linz Data vFINAL.pdf
Total size =152K